The effectiveness of microneedling and cosmetic camouflage in the treatment of vitiligo

Abstract

BACKGROUND: Treatment of vitiligo is one of the most difficult problems in dermatology. Despite the availability of various safe and effective methods of treatment, there are problems with combining and correctly applying techniques for the most effective result. Vitiligo has an impact on the psycho-social aspects of patients' daily life. This makes it necessary to use additional techniques, such as cosmetic camouflage to improve the quality of life of patients with vitiligo.

AIM: to assess the effectiveness of microneedling and cosmetic camouflage for the treatment of vitiligo.

MATERIALS AND METHODS: The study included 78 people with vitiligo aged 28–46 years. At the first stage of the study, 49 patients underwent microneedling in combination with ultraviolet B therapy and local tacrolimus. The subjects of the control group (n=29) were affected only by ultraviolet B therapy and tacrolimus. Phototherapy with ultraviolet B rays of 311 nm was carried out according to the method of 3-fold irradiation per week (Monday, Wednesday, Friday) with an initial dose of 0.05 J/cm². 0.1% tacrolimus ointment was applied twice a day during the course of therapy. The treatment lasted for 2–5 months; 2 courses of 2 months were carried out with a break of 3 months (in total 5 months). On average, for therapeutic effect (complete or partial repigmentation), patients received 60–64 sessions. Patients of the studied groups underwent a comparative analysis of repigmentation 2 and 5 months after treatment. At the second stage of the study, patients after microneedling were divided into the main group (n=33) and the comparison group (n=16). The subjects of the comparison group underwent cosmetic camouflage of vitiligo sites. Before and after treatment, the dermatological index of quality of life was determined for patients.

RESULTS: After 1 month from the start of treatment, 67.4% of patients after microneedling and 6.1% of patients in the control group showed moderate improvement (26–50% repigmentation). There was a good improvement with 51–75% repigmentation in 26.5% of patients after microneedling. After 5 months from the start of treatment, 67.4% of the subjects after microneedling showed an improvement in repigmentation of more than 51%. It was found that the average indicators of the dermatological quality of life index after treatment in patients of the main group (9.6±0.3 points) and the comparison group (7.0±0.3 points) corresponded to the values of "moderate effect of the disease on quality of life" and were significantly (p=0.018) lower than the baseline level (20.8±0.2 points and 19.9±1.1 points). This was not determined in the control group (18.2±0.4 points and 22.4±0.1 points). In the comparison group, this indicator was significantly (p=0.001) lower in comparison with the scores of other study groups.

CONCLUSION: The combination of microneedling, ultraviolet B therapy and tacrolimus is an effective method of treating patients with vitiligo. It increases repigmentation and quality of life. Additional cosmetic camouflage improves various aspects of the life of patients with vitiligo.

Keywords

vitiligo / microneedling / camouflage / repigmentation / quality of life

References

[1] Bergqvist C, Ezzedine K. Vitiligo: A review. Dermatology. 2020;236(6):571–592. doi: 10.1159/000506103

[2] Bergqvist C., Ezzedine K. Vitiligo: A review // Dermatology. 2020. Vol. 236, N 6. P. 571–592. doi: 10.1159/000506103

[3] Lomonosov KM, Rem MA, Gorb VA. History of vitiligo experimental study. Russ J Skin Venereal Dis. 2017;20(6):378–380. (In Russ). doi: 10.18821/1560-9588-2017-20-6-378-380

[4] Ломоносов К.М., Рем М.А., Горб В.А. История экспериментального изучения витилиго // Российский журнал кожных и венерических болезней. 2017. Т. 20, № 6. C. 378–380. doi: 10.18821/1560-9588-2017-20-6-378-380

[5] Mina M, Elgarhy L, Al-Saeid H, Ibrahim Z. Comparison between the efficacy of microneedling combined with 5-fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo. J Cosmet Dermatol. 2018;17(5):744–751. doi: 10.1111/jocd.12440

[6] Mina M., Elgarhy L., Al-Saeid H., Ibrahim Z. Comparison between the efficacy of microneedling combined with 5-fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo // J Cosmet Dermatol. 2018. Vol. 17, N 5. P. 744–751. doi: 10.1111/jocd.12440

[7] Juntongjin P, Toncharoenphong N. Effectiveness of a combined 308-nm excimer lamp and topical mid-potent steroid treatment for facial vitiligo: a preliminary, randomized double-blinded controlled study. Lasers Med Sci. 2020;35(9):2023–2029. doi: 10.1007/s10103-020-03048-5

[8] Juntongjin P., Toncharoenphong N. Effectiveness of a combined 308-nm excimer lamp and topical mid-potent steroid treatment for facial vitiligo: A preliminary, randomized double-blinded controlled study // Lasers Med Sci. 2020. Vol. 35, N 9. P. 2023–2029. doi: 10.1007/s10103-020-03048-5

[9] De Baat C, Phoa KH, Zweers PG, et al. Medicaments and oral healthcare. Hyperpigmentation of oral soft tissues due to afamelanotide. Ned Tijdschr Tandheelkd. 2020;127(4):237–243. doi: 10.5177/ntvt.2020.04.19115

[10] De Baat C., Phoa K.H., Zweers P.G., et al. Medicaments and oral healthcare. Hyperpigmentation of oral soft tissues due to afamelanotide // Ned Tijdschr Tandheelkd. 2020. Vol. 127, N 4. P. 237–243. doi: 10.5177/ntvt.2020.04.19115

[11] Mokhtari F, Bostakian A, Shahmoradi Z, et al. Potential emerging treatment in vitiligo using Er:YAG in combination with 5FU and clobetasol. J Cosmet Dermatol. 2018;17(2):165–170. doi: 10.1111/jocd.12373

[12] Mokhtari F., Bostakian A., Shahmoradi Z., et al. Potential emerging treatment in vitiligo using Er:YAG in combination with 5FU and clobetasol // J Cosmetic Dermatol. 2018. Vol. 17, N 2. P. 165–170. doi: 10.1111/jocd.12373

[13] Rodrigues M, Ezzedine K, Hamzavi I, et al. Current and emerging treatments for vitiligo. J Am Acad Dermatol. 2017;77(1):17–29. doi: 10.1016/j.jaad.2016.11.010

[14] Rodrigues M., Ezzedine K., Hamzavi I., et al.; Vitiligo Working Group. Current and emerging treatments for vitiligo // J Am Acad Dermatol. 2017. Vol 77, N 1. P. 17–29. doi: 10.1016/j.jaad.2016.11.010

[15] Gan EY, Eleftheriadou V, Esmat S, et al. Repigmentation in vitiligo: Position paper of the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2017;30(1):28–40. doi: 10.1111/pcmr.12561

[16] Gan E.Y., Eleftheriadou V., Esmat S., et al. Repigmentation in vitiligo: Position paper of the Vitiligo Global Issues Consensus Conference // Pigment Cell Melanoma Res. 2017. Vol. 30, N 1. P. 28–40. doi: 10.1111/pcmr.12561

[17] Pinson IY, Olisova OY, Bashlakova KA. Clinical efficiency of eximer lamp and laser in vitiligo: A comparative randomized study. Russ J Skin Venereal Dis. 2015;18(5):59–62. (In Russ). doi: 10.17816/dv37025

[18] Пинсон И.Я., Олисова О.Ю., Башлакова К.А. Сравнение клинической эффективности эксимерных лампы и лазера при витилиго: рандомизированное исследование // Российский журнал кожных и венерических болезней. 2015. Т. 18, № 5. C. 59–62. doi: 10.17816/dv37025

[19] Iriarte C, Awosika O, Rengifo-Pardo M, Ehrlich A. Review of applications of microneedling in dermatology. Clin Cosmet Investig Dermatol. 2017;(10):289–298. doi: 10.2147/CCID.S142450

[20] Iriarte C., Awosika O., Rengifo-Pardo M., Ehrlich A. Review of applications of microneedling in dermatology // Clin Cosmet Investig Dermatol. 2017. Vol. 10. P. 289–298. doi: 10.2147/CCID.S142450

[21] Stanimirovic A, Kovacevic M, Korobko I, et al. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB. Dermatol Ther. 2016;29(5):312–316. doi: 10.1111/dth.12363

[22] Stanimirovic A., Kovacevic M., Korobko I., et al. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB // Dermatol Ther. 2016. Vol. 29, N 5. P. 312–316. doi: 10.1111/dth.12363

[23] Giorgio CM, Caccavale S, Fulgione E, et al. Efficacy of microneedling and photodynamic therapy in vitiligo. Dermatol Surg. 2019;45(11):1424–1426. doi: 10.1097/DSS.0000000000001816

[24] Giorgio C.M., Caccavale S., Fulgione E., et al. Efficacy of microneedling and photodynamic therapy in vitiligo // Dermatol Surg. 2019. Vol. 45, N 11. P. 1424–1426. doi: 10.1097/DSS.0000000000001816

[25] Wu JH, Cohen BA. The stigma of skin disease. Curr Opin Pediatr. 2019;31(4):509–514. doi: 10.1097/MOP.0000000000000792

[26] Wu J.H., Cohen B.A. The stigma of skin disease // Curr Opin Pediatr. 2019. Vol. 31, N 4. P. 509–514. doi: 10.1097/MOP.0000000000000792

[27] Tanioka M, Yamamoto Y, Kato M, Miyachi Y. Camouflage for patients with vitiligo vulgaris improved their quality of life. J Cosmet Dermatol. 2010;9(1):72–75. doi: 10.1111/j.1473-2165.2010.00479.x

[28] Tanioka M., Yamamoto Y., Kato M., Miyachi Y. Camouflage for patients with vitiligo vulgaris improved their quality of life // J Cosmet Dermatol. 2010. Vol. 9, N 1. P. 72–75. doi: 10.1111/j.1473-2165.2010.00479.x

[29] Salloum A, Bazzi N, Maalouf D, Habre M. Microneedling in vitiligo: A systematic review. Dermatol Ther. 2020;33(6):e14297. doi: 10.1111/dth.14297

[30] Salloum A., Bazzi N., Maalouf D., Habre M. Microneedling in vitiligo: A systematic review // Dermatol Ther. 2020. Vol. 33, N 6. P. e14297. doi: 10.1111/dth.14297

[31] Morrison B, Burden-Teh E, Batchelor JM, et al. Quality of life in people with vitiligo: A systematic review and meta-analysis. Br J Dermatol. 2017;177(6):e338–e339. doi: 10.1111/bjd.15933

[32] Morrison B., Burden-Teh E., Batchelor J.M., et al. Quality of life in people with vitiligo: A systematic review and meta-analysis // Br J Dermatol. 2017. Vol. 177, N 6. P. e338–e339. doi: 10.1111/bjd.15933

[33] Elbuluk N, Ezzedine K. Quality of life, burden of disease, co-morbidities, and systemic effects in vitiligo patients. Dermatol Clin. 2017;35(2):117–128. doi: 10.1016/j.det.2016.11.002

[34] Elbuluk N., Ezzedine K. Quality of life, burden of disease, co-morbidities, and systemic effects in vitiligo patients // Dermatol Clin. 2017. Vol. 35. P. 117–128. doi: 10.1016/j.det.2016.11.002

RIGHTS & PERMISSIONS

Lecaillon M.G., Lomonosov K.M., Krotkova E.A.